Emergency Committee on COVID-19 advises on variants, vaccines

PUBLISHED: Fri, 15 Jan 2021 16:46:02 GMT
Share

Content provided by APO Group. CNBC Africa provides content from APO Group as a service to its readers, but does not edit the articles it publishes. CNBC Africa is not responsible for the content provided by APO Group.
Download logo

The COVID-19 pandemic continues to constitute a Public Health Emergency of International Concern (PHEIC), according to the WHO Emergency Committee (EC) on COVID-19.

The EC met virtually yesterday (14 January) at the request of WHO Director-General Dr Tedros Adhanom Ghebreyesus to review the emerging variants of SARS-CoV-2, the virus that causes COVID-19, and to consider the potential use of vaccination and testing certificates for international travel.

On variants, the EC called for a global expansion of genomic sequencing and sharing of data, along with greater scientific collaboration to address critical unknowns.

The committee urged WHO to develop a standardized system for naming new variants that avoids geographical markers, an area WHO has already begun work on.

On vaccines, the committee underlined the need for equitable access through the COVAX Facility as well as technology transfer to increase global production capacities.

The committee strongly encouraged vaccine manufacturers to rapidly provide safety and efficacy data to WHO for emergency use listing. The lack of such data is a barrier to ensuring the timely and equitable supply of vaccines at the global level. 

Given that the impact of vaccines in reducing transmission is yet unknown, and the current availability of vaccines is too limited, the committee recommended that countries do not require proof of vaccination from incoming travellers.

The committee advised countries to implement coordinated, evidence-based measures for safe travel and to share with WHO experiences and best practices learned.

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.

This was the sixth meeting of the Emergency Committee on COVID-19. Since the declaration of a PHEIC on 30 January 2020, the Director-General has been reconvening the committee at three-month intervals to review progress. 

Distributed by APO Group on behalf of World Health Organization (WHO).